Commercial prices for health services, especially hospital care, are expensive, highly varied, but opaque in the US. They leave patients and employers uninformed and disadvantaged when purchasing care. Price transparency policies are seen as an approach to empower patients and employers to compare prices, stimulate price competition, and contain healthcare expenditures. In this webinar panel, we’re bringing together experts from academia, government, and private sector to explore key questions around the policy regulation, data, and practical implications for commercial health plans and pricing
Panelists
-
- Dr. Christopher Whaley, associate professor from Brown University
- Ms. Elizabeth Mitchell, CEO of Purchaser Business Group on Health (PBGH)
- Mr. Joeseph Wisniewski, associated director from Turquoise Health
Moderator
Dr. Yang Wang is a health economist in the Department of Health Policy and Management at Bloomberg School of Public Health.
This event is part of a larger series on the 'Conversations on the Business of Health,' which will be one-hour webinars that will engage leaders in business and academia. We will explore questions such as: Should companies invest in their employees’ health? Will artificial intelligence actually advance health? How can business offer healthcare in novel settings?